Overview Fundamentals API Earnings EOD API Sample Code Pricing

Strides Pharma Science Limited (STAR NSE) stock market data APIs

INR1401.6 -24.75(-1.7%) as of November 26, 2024
Price chart is built with Anychart

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

Strides Pharma Science Limited Financial Data Overview

1426.35
1401.6
-
1440
1401.6
481.1138-1675
131 165 M
73.4475
91 958 K
44 103 M
-13.46
0.0018
0.73
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'STAR',
Type: 'Common Stock',
Name: 'Strides Pharma Science Limited',
Exchange: 'NSE',
CurrencyCode: 'INR',
CurrencyName: 'Indian Rupee',
CurrencySymbol: 'INR',
CountryName: 'India',
CountryISO: 'IN',
OpenFigi: NULL,
ISIN: 'INE939A01011',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

Strides Pharma Science Limited Fundamental Data is available in our Financial Data APIs

  • Net Revenue 44 103 M
  • EBITDA 8 240 M
  • Earnings Per Share 19.42
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Strides Pharma Science Limited Earnings via APIs

  • Latest Release 2024-05-22
  • EPS/Forecast 4.2

Get Strides Pharma Science Limited End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com